Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$718M |
| 2 |
Microsoft
MSFT
|
+$662M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$404M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$342M |
| 5 |
NVIDIA
NVDA
|
+$187M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$713M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$711M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$709M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$626M |
| 5 |
Home Depot
HD
|
+$561M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.54% |
| 2 | Healthcare | 5.02% |
| 3 | Consumer Discretionary | 4.7% |
| 4 | Financials | 4.22% |
| 5 | Communication Services | 3.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
CALL
Aurinia Pharmaceuticals
AUPH
$1.95B
| $483K | ﹤0.01% |
+49,900
| New | +$518K |
|
|
3302
PUT
Aurinia Pharmaceuticals
AUPH
$1.95B
| $483K | ﹤0.01% |
+49,900
| New | +$518K |
|
3303
Hudbay
HBM
$9.76B
| $482K | ﹤0.01% |
100,351
-2,878
| -3% | -$14.1K |
|
3304
Aurora
AUR
$11.7B
| $481K | ﹤0.01% |
163,772
-1,445,338
| -90% | -$2.42M |
|
3305
MiMedx Group
MDXG
$630M
| $480K | ﹤0.01% |
72,670
-65,581
| -47% | -$334K |
|
3306
Alector
ALEC
$169M
| $480K | ﹤0.01% |
79,911
-128,265
| -62% | -$896K |
|
3307
National Presto Industries
NPK
$870M
| $478K | ﹤0.01% |
6,530
+759
| +13% | +$55.8K |
|
3308
Crane NXT
CXT
$2.99B
| $476K | ﹤0.01% |
8,433
-12,186
| -59% | -$619K |
|
|
RDFN
3309
DELISTED
Redfin
RDFN
| $475K | ﹤0.01% |
38,276
+34,789
| +998% | +$339K |
|
3310
Under Armour Class C
UA
$2.95B
| $475K | ﹤0.01% |
70,828
+36,765
| +108% | +$270K |
|
|
BWIN
3311
Baldwin Insurance Group
BWIN
$2.75B
| $475K | ﹤0.01% |
19,175
+17,632
| +1,143% | +$417K |
|
3312
Designer Brands
DBI
$315M
| $475K | ﹤0.01% |
47,032
+14,386
| +44% | +$119K |
|
3313
American Vanguard Corp
AVD
$68.7M
| $475K | ﹤0.01% |
26,554
+8,349
| +46% | +$154K |
|
3314
CALL
Bunge Global
BG
$20.9B
| $472K | ﹤0.01% |
+5,000
| New | +$464K |
|
3315
Invesco S&P MidCap Low Volatility ETF
XMLV
$762M
| $471K | ﹤0.01% |
9,102
-381
| -4% | -$19.6K |
|
|
XRN
3316
Chiron Real Estate Inc
XRN
$535M
| $470K | ﹤0.01% |
10,306
+4,613
| +81% | +$208K |
|
3317
CALL
Alkermes
ALKS
$8.11B
| $470K | ﹤0.01% |
15,000
| – | – |
|
|
3318
PUT
Alkermes
ALKS
$8.11B
| $470K | ﹤0.01% |
15,000
| – | – |
|
3319
Nurix Therapeutics
NRIX
$2.45B
| $469K | ﹤0.01% |
46,960
-66,144
| -58% | -$675K |
|
|
HMA
3320
DELISTED
Heartland Media Acquisition Corp.
HMA
| $469K | ﹤0.01% |
44,500
| – | – |
|
|
EBIX
3321
DELISTED
Ebix Inc
EBIX
| $468K | ﹤0.01% |
18,585
+7,265
| +64% | +$136K |
|
|
ALX
3322
Alexander's
ALX
$1.36B
| $466K | ﹤0.01% |
2,532
+637
| +34% | +$115K |
|
3323
TTEC Holdings
TTEC
$124M
| $465K | ﹤0.01% |
13,755
+5,197
| +61% | +$178K |
|
3324
Community Health Systems
CYH
$382M
| $465K | ﹤0.01% |
105,783
+35,162
| +50% | +$150K |
|
3325
Compass Diversified
CODI
$752M
| $463K | ﹤0.01% |
21,364
+18,877
| +759% | +$375K |
|
Similar funds
Citigroup's Q2 2023 Portfolio in Review
As of Q2 2023, Citigroup held 5,906 positions worth $153B, up 6.9% from $143B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Citigroup's Q2 2023 filing shows 463 new, 2,756 increased, 1,590 reduced and 354 closed positions. Its largest new stake was Vesta Real Estate: 3,353,619 shares worth $108M. The largest sale was iShares Russell 2000 ETF, an estimated $713M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 9.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Citigroup's largest Q2 2023 buy was Vesta Real Estate: 3,353,619 shares worth $108M.
- Citigroup added most to Vanguard Morningstar Total Stock Market ETF in Q2 2023, an estimated $718M increase.
- Citigroup's biggest Q2 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $713M.
- Citigroup fully exited DCP Midstream, LP in Q2 2023, selling an estimated $198M.
- Citigroup's ten largest holdings make up 34% of its $153B portfolio in Q2 2023.
- Citigroup opened 463 new positions and closed 354 in Q2 2023.
- Citigroup's portfolio value rose 6.9% quarter-over-quarter to $153B.
Based on Citigroup's 13F filing for Q2 2023, filed 10 Aug 2023.